DERMATA THERAPEUTICS INC (DRMA) Stock Income Statement
NASDAQ:DRMA • US2498455045
Current stock price
1.36 USD
+0.01 (+0.74%)
At close:
1.38 USD
+0.02 (+1.47%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.77M | 12.51M | 8.04M | 9.67M | 7.86M | |||
| Research and Development | 2.93M | 8.20M | 4.07M | 5.65M | 3.46M | |||
| Selling, General, and Administrative Expenses | 4.84M | 4.31M | 3.97M | 4.02M | 4.40M | |||
| Operating Income | -7.77M | -12.51M | -8.04M | -9.67M | -7.86M | |||
| Interest Income/Expense | 215.00K | 225.80K | 247.20K | 63.60K | -45.60K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -7.56M | -12.29M | -7.79M | -9.61M | -7.90M | |||
| Net Income | -7.56M | -12.29M | -7.79M | -9.61M | -10.46M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.16 | -80.32 | -399.72 | -2.09K | -3.02K | |||
| Non GAAP EPS | -9.33 | -153.30 | -547.50 | -2.21K | N/A | |||
| Statistics | ||||||||
All data in USD